Crestline Management, LP Medicinova Inc Transaction History
Crestline Management, LP
- $1.88 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding MNOV
# of Institutions
31Shares Held
4.83MCall Options Held
9.4KPut Options Held
6K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.17 Million0.67% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA506KShares$991,6930.0% of portfolio
-
Citigroup Inc448KShares$877,9950.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $96.1M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...